White Papers

Increasing Drug Impact Through Patient Support Programs

Posted February 17, 2017|

Patient empowerment is on the rise and it has become increasingly important for drug companies to develop patient-centric approaches that include the redesign of patient support programs to increase product loyalty and prevent patients from switching to competing products. Initially, companies offered patient support programs to improve access to and usage of drugs and adherence to drug protocols; recently, these programs have expanded.

In turn, pharmaceutical and other health companies need to shift their approach to the marketplace to satisfy patient demands.


Download the Whitepaper:

Tags: , , ,

Related Resources

Read More

Fuld + Company’s Initial Perspectives on the Impact of Covid-19: Emerging Opportunities Across Industries

After several weeks of observing and examining the actions of businesses, government and other participants in the U.S economy, Fuld […]

Read More

2019 Pharma Companies to Watch Report

This proprietary qualitative analysis identifies five top pharmaceutical companies that stand out as major disruptors. Fuld + Company’s analysis includes […]

Read More

Competitive Intelligence (CI) Dictionary

Competitive Intelligence is the collection and analysis of information to anticipate competitive activity, see past market disruptions and dispassionately interpret […]

Subscribe to our mailing list for our latest updates: